Literature DB >> 3129547

Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.

T J Rimele1, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman, D Grimes.   

Abstract

Experiments were designed to study the interaction of rat peritoneal neutrophils with the vascular smooth muscle of the rat aorta. Rings of aorta, suspended in 10-ml organ chambers containing a physiologic salt solution, were precontracted with phenylephrine. Neutrophils (1 X 10(5) -4 X 10(7) cells/organ chamber) caused a cell number-dependent relaxation of the rat aorta that was augmented by superoxide dismutase (100 U/ml) or changing the oxygen content from 95 to 21%. The neutrophil-induced smooth muscle relaxation occurred in rings with and without endothelium and in rings precontracted with increasing concentrations of phenylephrine, prostaglandin F2 alpha or KCI. Catalase (1000 U/ml) and mannitol (1 X 10(-3) M) did not block the neutrophil-induced relaxation, whereas phenazine methosulfate (1 X 10(-5) M), hydroquinone (3 X 10(-5) M) and methylene blue (1 X 10(-5) M) reversed the neutrophil-induced relaxation. Pre-exposure of endothelium-rubbed rings to neutrophils (2 X 10(7) cells/organ chamber; 15 min) depressed the subsequent concentration-response curve to phenylephrine but augmented the relaxation induced by the phosphodiesterase inhibitor zaprinast (1 X 10(-5) M). The effluent from a column restraining the neutrophils induced a relaxation of endothelium-rubbed aortic rings that was prevented by methylene blue (1 X 10(-5) M). These results demonstrate that rat neutrophils release a factor that has a pharmacologic profile similar to that previously reported for the relaxing factor released from the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129547

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro.

Authors:  W C Sessa; K M Mullane
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

2.  The cytosol of N1E-115 neuroblastoma cells synthesizes an EDRF-like substance that relaxes rabbit aorta.

Authors:  U Förstermann; K Ishii; L D Gorsky; F Murad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

3.  Leucocyte-induced endothelium-dependent vasodilatation and post-ischaemic vasospasm in the isolated rat superior mesenteric artery.

Authors:  H J Grossman; M Zambetis
Journal:  Br J Exp Pathol       Date:  1989-10

4.  N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.

Authors:  S Pou; W S Pou; G M Rosen; E E el-Fakahany
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

5.  Modulation of cholinergic and substance P-like neurotransmission by nitric oxide in the guinea-pig ileum.

Authors:  C U Wiklund; C Olgart; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.

Authors:  A Dembinska-Kiec; D Pallapies; T Simmet; B M Peskar; B A Peskar
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 7.  Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Authors:  L J Ignarro
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

8.  Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release.

Authors:  C Bernard; B Szekely; I Philip; E Wollman; D Payen; A Tedgui
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.

Authors:  C Thiemermann; M Mustafa; P A Mester; J A Mitchell; M Hecker; J R Vane
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions.

Authors:  E Moilanen; P Vuorinen; H Kankaanranta; T Metsä-Ketelä; H Vapaatalo
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.